title: Relationship between structure and drug-induced parkinsonism.
authors.forename: Y
authors.initials: Y
authors.lastname: Sawada
authors.forename: R
authors.initials: R
authors.lastname: Nasu
authors.forename: H
authors.initials: H
authors.lastname: Matsuo
authors.forename: H
authors.initials: H
authors.lastname: Ohtani
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D002375:Catalepsy / Q000139:chemically induced; D002936:Cinnarizine / Q000009:adverse effects; D015195:Drug Design; D005444:Flunarizine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D014665:Vasodilator Agents; D002936:Cinnarizine; D006220:Haloperidol; D005444:Flunarizine